Ziming Li

2.2k total citations · 1 hit paper
71 papers, 1.3k citations indexed

About

Ziming Li is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ziming Li has authored 71 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 27 papers in Oncology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ziming Li's work include Cancer Immunotherapy and Biomarkers (13 papers), Lung Cancer Treatments and Mutations (11 papers) and Epigenetics and DNA Methylation (8 papers). Ziming Li is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Lung Cancer Treatments and Mutations (11 papers) and Epigenetics and DNA Methylation (8 papers). Ziming Li collaborates with scholars based in China, United States and Switzerland. Ziming Li's co-authors include Shun Lü, Xiaomin Niu, Wenxiang Ji, Weiliang Xia, Yongfeng Yu, Shengping Shen, Ying Yang, Kaixuan Wang, Xiangyun Ye and Yongfeng Yu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ziming Li

65 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A reactive oxygen species-responsive hydrogel encapsulated with bone marrow derived stem cells promotes repair and regeneration of spinal cord injury

2022 110 citations Ziming Li et al. profile →

Peers

Countries citing papers authored by Ziming Li

Since Specialization

Citations

This map shows the geographic impact of Ziming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziming Li more than expected).

Fields of papers citing papers by Ziming Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziming Li. The network helps show where Ziming Li may publish in the future.

Co-authorship network of co-authors of Ziming Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ziming Li. A scholar is included among the top collaborators of Ziming Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziming Li. Ziming Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	New Drug Approvals in China: An International Comparative Analysis, 2019-2023 2025 ·Drug Design Development and Therapy ·(unknown), (unknown), Ziming Li, Weilin Shi, (unknown), (unknown), (unknown), Zhigang Zhao	1
2	Deciphering gonadal transcriptome reveals circRNA-miRNA-mRNA regulatory network involved in sex differentiation and gametogenesis of Apostichopus japonicus 2025 ·Molecular Genetics and Genomics ·Ziming Li, Xinyue Tang, Xinghai Liu, Jing Huo, Ying Guo, Yujia Yang	0
3	Transcriptomic profile of RNA pseudouridine modification as a biomarker for cellular senescence associated with survival outcomes in colorectal cancer 2025 ·BMC Biology ·(unknown), (unknown), (unknown), (unknown), (unknown), Yuanhui Wu, (unknown), Junyi Han, Xuan Li, (unknown), (unknown), Ziming Li, Zhenghua Chen, Ji Cui, Yanxin Luo, Meijin Huang, Huichuan Yu, Jinxin Lin	1
4	NLRP4 unlocks an NK/macrophages-centered ecosystem to suppress non-small cell lung cancer 2025 ·Biomarker Research ·(unknown), Jian Li, Hui Wang, (unknown), Wenqing Lü, Xiaomin Niu, Yi Yang, Ziming Li, Ying Wang, Shun Lü	1
5	Integration analysis of microRNAs and mRNA reveals a regulatory mechanism in gonadal differentiation of sea cucumber Apostichopus japonicus 2025 ·Aquaculture International ·Xinghai Liu, Ziming Li, Xinyue Tang, Ying Guo, Yujia Yang	1
6	Analysis of gonadal transcriptome reveals core long non-coding RNA-mRNA regulatory network in sea cucumber Apostichopus japonicus 2024 ·Comparative Biochemistry and Physiology Part D Genomics and Proteomics ·Ziming Li, Xinghai Liu, Xinyue Tang, (unknown)	1
7	Enzyme-armed nanocleaner provides superior detoxification against organophosphorus compounds via a dual-action mechanism 2024 ·Journal of Nanobiotechnology ·Qin Kang, Fei Meng, Dianpeng Han, (unknown), Xinyi Li, Ziming Li, (unknown), Huanying Zhou, Hongyuan Yan, Yuan Peng, Zhixian Gao	2
8	Video-Assisted Thoracoscopic Surgery Versus Thoracotomy Following Neoadjuvant Immunochemotherapy in Resectable Stage III Non-Small Cell Lung Cancer Among Chinese Populations: A Multi-Center Retrospective Cohort Study 2024 ·Clinical Lung Cancer ·(unknown), Hang Chen, Weicheng Kong, (unknown), Zhen Ge, (unknown), (unknown), (unknown), Jiaqi Zhang, (unknown), (unknown), (unknown), (unknown), Long Jiang, Ziming Li, Jia Huang, Chengwei Zhou, Guodong Xu, Qingquan Luo	6
9	Combination of percutaneous thermal ablation and adoptive Th9 cell transfer therapy against non-small cell lung cancer 2024 ·Experimental Hematology and Oncology ·(unknown), (unknown), Siyu Pei, Wanlin Yang, Yanyang Zhang, (unknown), (unknown), (unknown), (unknown), Jiang Long, Yingjie Hu, Shengping Shen, Kai Wang, Haizhen Jin, Ziming Li, Yanyun Zhang, Yichuan Xiao, Qingquan Luo, Hui Wang, Jia Huang	8
10	Impaired hemoglobin clearance by sinusoidal endothelium promotes vaso-occlusion and liver injury in sickle cell disease 2023 ·Haematologica ·Tomasz W. Kamiński, (unknown), Ziming Li, (unknown), (unknown), (unknown), Tomasz Brzóska, Hong Zhang, Prithu Sundd, Gregory J. Kato, Enrico M. Novelli, Tirthadipa Pradhan‐Sundd	5
11	Clinicopathological characteristics and treatment outcomes of advanced SMARCA4‐deficient thoracic tumors 2023 ·Cancer Medicine ·(unknown), Yueping Jin, (unknown), (unknown), Ziming Li	5
12	Sleeve Lobectomy After Neoadjuvant Chemoimmunotherapy Versus Chemotherapy for Squamous Cell Lung Cancer: A Multicenter, Retrospective Study 2023 ·JTO Clinical and Research Reports ·Tianxiang Chen, (unknown), Jianfei Shen, Hui Pan, (unknown), Enwu Xu, Han Wu, Jia Huang, Yunhai Yang, Ziming Li, Qingquan Luo	3
13	Short-term outcomes of robot-assisted versus video-assisted thoracoscopic surgery for non-small cell lung cancer patients with neoadjuvant immunochemotherapy: a single-center retrospective study 2023 ·Frontiers in Immunology ·(unknown), (unknown), Yu Tian, (unknown), Jiaqi Zhang, Weiqiu Jin, (unknown), (unknown), Ziming Li, Weicheng Kong, Long Jiang, Jia Huang, Qingquan Luo	7
14	Radiographic Assessment of Aseptic Loosening of Tumor‐Type Knee Prosthesis in Distal Femur 2022 ·Orthopaedic Surgery ·Ziming Li, Xiuchun Yu, Kai Zheng	2
15	Neoadjuvant PD-1 Inhibitors and Chemotherapy for Locally Advanced NSCLC: A Retrospective Study 2021 ·The Annals of Thoracic Surgery ·Tianxiang Chen, (unknown), Alessio Campisi, Andrea Dell’Amore, (unknown), Ziming Li, Liwei Song, Jia Huang, Yunhai Yang, Franco Stella, Qingquan Luo	26
16	Enhanced autocrine FGF19/FGFR4 signaling drives the progression of lung squamous cell carcinoma, which responds to mTOR inhibitor AZD2104 2020 ·Oncogene ·Fan Li, Ziming Li, Qing Han, Yirui Cheng, Wenxiang Ji, Ying Yang, Shun Lü, Weiliang Xia	30
17	MicroRNA-214-3p inhibits the stem-like properties of lung squamous cell cancer by targeting YAP1 2020 ·Cancer Cell International ·Tingting Lü, Ying Yang, Ziming Li, Shun Lu	16
18	PAK5 promotes the cell stemness ability by phosphorylating SOX2 in lung squamous cell carcinomas 2020 ·Experimental Cell Research ·(unknown), Wenxiang Ji, Ying Yang, Zhuo Chen, Ziming Li, Kaixuan Wang, Tingting Lü, Yongfeng Yu, Weiliang Xia, Shun Lü	8
19	High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients 2017 ·Proceedings of the National Academy of Sciences ·Yin Tang, Zhuo Wang, Ziming Li, Jung-Woo Kim, Yuliang Deng, Yan Li, James R. Heath, Wei Wei, (unknown), Qihui Shi	58
20	Genome-wide DNA Methylation Analysis Reveals GABBR2 as a Novel Epigenetic Target for EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment 2017 ·Clinical Cancer Research ·Xiaomin Niu, Fatao Liu, Yi Zhou, Zhen Zhou, Daizhan Zhou, Ting Wang, Ziming Li, Xiangyun Ye, Yongfeng Yu, Xiaoling Weng, Hong Zhang, Junyi Ye, Meilin Liao, Yun Liu, Zhiwei Chen, Shun Lü	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact